Here’s an ethical question…
Suppose a sell-side research analyst visits with a company that he covers on Monday. Then, on Tuesday, he attends the morning internal sales/trading meeting at his firm and announces his findings, but isn’t changing EPS estimates or stock rating. Then, later on Tuesday, he e-mails a personalized e-mail with his findings to select top clients. Then, on Friday, he issues a research note with his findings to all clients.
This is a clear violation of III(B) - Fair Dealing, right? Or does the analyst’s “announcement” in the internal sales/trading meeting (as the institutional sales force can then go and call clients with the information) constitute sufficient dissemination of his opinion?